Lexeo Therapeutics, Inc. Common Stock
USD4.75
+0.05 (+1.06%)
CEO
R. Nolan Townsend
IPO Date
2023-11-03
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$4.69
Prev. Close
$4.70
Day Low
$4.67
Day High
$4.92
52W Low
$3.60
52W High
$10.99
Market Cap
$0.37B
Volume
2.34M
| 3,342 |
| $5.06 |
| 30 Apr 2026 | Sepp-Lorenzino Laura | director | A-Award | Acquired | 50,000 | $5.81 |
| 30 Apr 2026 | Sepp-Lorenzino Laura | — | Disposed | 0 | $0.00 |
| 7 Apr 2026 | Townsend Richard Nolan | director, officer: Chief Executive Officer | S-Sale | Disposed | 55,000 | $5.69 |
| 17 Mar 2026 | Townsend Richard Nolan | director, officer: Chief Executive Officer | A-Award | Acquired | 2,623 | $2.64 |
| 17 Mar 2026 | Otero Jose Manuel | Chief Operating Officer | A-Award | Acquired | 5,930 | $2.64 |
| 20 Feb 2026 | Otero Jose Manuel | Chief Operating Officer | S-Sale | Disposed | 3,016 | $6.40 |
| 20 Feb 2026 | Townsend Richard Nolan | director, officer: Chief Executive Officer | S-Sale | Disposed | 10,173 | $6.38 |
| 20 Feb 2026 | Otero Jose Manuel | Chief Operating Officer | S-Sale | Disposed | 721 | $9.27 |